Home Alzheimer’s Disease Immunotherapy Among Patients with Melanoma and the Checkpoint Inhibitor Era

Immunotherapy Among Patients with Melanoma and the Checkpoint Inhibitor Era

The distribution of immunotherapy for patients with stage IV melanoma was unequal, and the rates of surgical resection did not differ with the use of immunotherapy between the checkpoint inhibitor era and pre-checkpoint inhibitor era, according to a study released in Cancer.

More, the patients who received immunotherapy in the checkpoint inhibitor era were more likely to be younger, be healthier, have private insurance, come from upper income quartiles, and be treated at academic programs.

“Use of immunotherapy significantly varied among patients with stage IV melanoma according to age, socioeconomic status, and treating facility,” wrote the researchers. “In comparison with the pre-checkpoint inhibitor era, the difference-in-difference analysis demonstrated that the approval of immunotherapy in 2011 was not associated with an increase in surgical resection of distant…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

All About Glioblastoma : braincancer

A splitting headache that continues non-stop. A weak spot in the muscular tissues and being unable to stroll a small distance. Feeling abnormally sleepy at random durations of the day.For many persons with glioblastoma...

please help us fundraise (501c3 non-profit) : braincancer

I work with OurBrainBank, a start-up non-profit dedicated to moving glioblastoma from terminal to treatable, powered by patients.We're a registered 501c3 non-profit in the...

Recent Comments